Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Dow
Baxter
McKesson
Express Scripts

Last Updated: May 25, 2022

Investigational Drug Information for PF-04965842


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for PF-04965842?

PF-04965842 is an investigational drug.

There have been 24 clinical trials for PF-04965842. The most recent clinical trial was a Phase 3 trial, which was initiated on March 8th 2018.

The most common disease conditions in clinical trials are Dermatitis, Atopic, Dermatitis, and Eczema. The leading clinical trial sponsors are Pfizer and [disabled in preview].

There are six US patents protecting this investigational drug and one hundred and thirty-eight international patents.

Recent Clinical Trials for PF-04965842
TitleSponsorPhase
Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic DermatitisPfizerPhase 2
Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy ParticipantsPfizerPhase 1
A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy ParticipantsPfizerPhase 1

See all PF-04965842 clinical trials

Clinical Trial Summary for PF-04965842

Top disease conditions for PF-04965842
Top clinical trial sponsors for PF-04965842

See all PF-04965842 clinical trials

US Patents for PF-04965842

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
PF-04965842 See Plans and Pricing Substituted indazoles for treating tendon and/or ligament injuries NOVARTIS AG (Basel, CH) See Plans and Pricing
PF-04965842 See Plans and Pricing Aza-indazole compounds for use in tendon and/or ligament injuries NOVARTIS AG (Basel, CH) See Plans and Pricing
PF-04965842 See Plans and Pricing Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof Pfizer Inc. (New York, NY) See Plans and Pricing
PF-04965842 See Plans and Pricing Pyrrolo[2,3-D]pyrimidine derivatives Pfizer Inc. (New York, NY) See Plans and Pricing
PF-04965842 See Plans and Pricing Pyrrolo[2,3-D]pyrimidine derivatives Pfizer Inc. (New York, NY) See Plans and Pricing
PF-04965842 See Plans and Pricing Pyrrolo[2,3-D]pyrimidine derivatives Pfizer Inc. (New York, NY) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for PF-04965842

Drugname Country Document Number Estimated Expiration Related US Patent
PF-04965842 Argentina AR109688 2036-09-23 See Plans and Pricing
PF-04965842 Australia AU2017332867 2036-09-23 See Plans and Pricing
PF-04965842 Brazil BR112019005578 2036-09-23 See Plans and Pricing
PF-04965842 Canada CA3033249 2036-09-23 See Plans and Pricing
PF-04965842 Chile CL2019000727 2036-09-23 See Plans and Pricing
PF-04965842 China CN109715608 2036-09-23 See Plans and Pricing
PF-04965842 Colombia CO2019002616 2036-09-23 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Dow
Baxter
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.